Red blood cell alloimmunization in Iranian beta‐thalassemia patients: a systematic review and meta‐analysis

P Darvishi, M Azami, K Sayehmiri… - ISBT Science …, 2016 - Wiley Online Library
Background and Objectives Red blood cell alloimmunization is associated with haemolytic
reactions and severe clinical consequences. The rate of alloimmunization in multitransfused …

The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran

MA Jalali Far, A Oodi, N Amirizadeh… - … Genetics & Genomic …, 2021 - Wiley Online Library
Introduction The alloimmunization following blood transfusion can be life‐threatening. The
Rh alloantibodies are one of the most common causes contributing to alloimmunization. This …

Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr

MS Gholami, M Shahidi, S Tabibian, M Naderi… - … and Apheresis Science, 2021 - Elsevier
Introduction Beta-thalassemia major is a severe hemolytic anemia requiring life-long blood
transfusion. Planned random donor blood transfusion is associated with alloimmunization …

Distribution of red blood cell alloantibodies among transfusion-dependent β-Thalassemia patients in different population of Iran: Effect of ethnicity

R Sarihi, N Amirizadeh, A Oodi, A Azarkeivan - Hemoglobin, 2020 - Taylor & Francis
The best approach for prevention of alloimmunization in β-thalassemia (β-thal) patients is
perfect matching of all red blood cell (RBC) antigens associated with clinically significant …

Frequency of Red Cell Alloimmunization in Patients with Thalassemia Major: A Report from the Southwest of Iran

B Keikhaei, H Yousefi, A Alghasi… - Iranian Journal of …, 2023 - publish.kne-publishing.com
Background: The mainstay of managing severe β-thalassemia remains lifelong blood
transfusion. Mismatched red blood cell phenotypes between donors and recipients in …

[PDF][PDF] Screening and identifying of erythrocyte alloantibodies in patients with Thalassemia major referred to Ahvaz Shafa hospital

Z Tahannejad-Asadi, A Elahi, A Mohseni… - Feyz Journals of …, 2013 - feyz.kaums.ac.ir
Background: Patients with thalassemia major are clinically dependent on red blood cell
(RBC) transfusions. Performing multiple transfusions increase the risk of transfusion-related …

Evaluation of the incidence of splenectomy and frequency of regular iron chelation therapy in patients with thalassemia Major in Iran: a meta-analysis

M Azami, S Nikpay, G Abangah… - Scientific Journal of Iran …, 2016 - bloodjournal.ir
Materials and Methods This study is based on documentations obtained from the databases
including Magiran, Iran medex, IranDoc, SID, Medlib, Embase, Scopus, Web of Science …

Evaluation of serum levels of C3 and C4 complement factors in patients with beta thalassemia major in Khuzestan Province, Southwest Iran

M Ghafourian, M Esmaeili… - … of Immunoassay and …, 2017 - Taylor & Francis
ABSTRACT Background and Objectives: Thalassemia syndrome is the most common
genetic disorder in the world and infection is the second cause of death in these patients …

[PDF][PDF] Prevalence of Anti-Erythrocyte Alloantibodies and Relevant Factors among the Patients with Thalassemia Major in Kermanshah, Iran

MR Golpayegany, MR Tohidi, S Hookari… - International Journal of …, 2020 - kums.ac.ir
Background The major treatment for thalassemia is a transfusion. The present study aimed
to determine the frequency of erythrocyte alloantibodies and the relevant factors among the …

A Review on Incidence of Alloimmunization with Incompatible Rh Blood Group Transfusion and Role of Molecular Methods in Finding Compatible Blood Units in Multi …

MT Hojati, MR Mahdavi - Journal of Mazandaran University of …, 2014 - jmums.mazums.ac.ir
Alloimunization reduces RBCs lifespan in circulation. Identification of phenotypes of RBCs
could be helpful in reducing the rate of alloimunization. But often, due to persistence of …